Global BCG Tuberculosis Vaccine Market: By Type (Immune BCG and Therapy BCG); Application (Hospital and Clinics); Region— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2023–2031
- Published Date: Jun-2023 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA0623469 | Delivery: 2 to 4 Hours
| Report ID: AA0623469 | Delivery: 2 to 4 Hours
TABLE 1 GLOBAL BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY REGION (2017-2023)
TABLE 2 GLOBAL BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY REGION (2024-2030)
TABLE 3 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY REGION (2017-2023)
TABLE 4 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUES (MILLION USD) BY REGION (2024-2030)
TABLE 5 GLOBAL BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2017-2023)
TABLE 6 GLOBAL BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2024-2030)
TABLE 7 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2017-2023)
TABLE 8 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2024-2030)
TABLE 9 GLOBAL BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2017-2023)
TABLE 10 GLOBAL BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2024-2030)
TABLE 11 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2017-2023)
TABLE 12 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2024-2030)
TABLE 13 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2017-2023
TABLE 14 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2024-2030)
TABLE 15 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY COUNTRY (2017-2023)
TABLE 16 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUES (MILLION USD) BY COUNTRY (2024-2030)
TABLE 17 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2017-2023)
TABLE 18 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2024-2030)
TABLE 19 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2017-2023)
TABLE 20 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2024-2030)
TABLE 21 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2017-2023)
TABLE 22 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2024-2030)
TABLE 23 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2017-2023)
TABLE 24 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2024-2030)
TABLE 25 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2017-2023)
TABLE 26 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2024-2030)
TABLE 27 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MILLION USD) BY COUNTRY (2017-2023)
TABLE 28 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY COUNTRY (2024-2030)
TABLE 29 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2017-2023)
TABLE 30 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2024-2030)
TABLE 31 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2017-2023)
TABLE 32 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2024-2030)
TABLE 33 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2017-2023)
TABLE 34 EUROPE BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2024-2030)
TABLE 35 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2017-2023)
TABLE 36 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2024-2030)
TABLE 37 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2017-2023)
TABLE 38 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2024-2030)
TABLE 39 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MILLION USD) BY COUNTRY (2017-2023)
TABLE 40 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY COUNTRY (2024-2030)
TABLE 41 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2017-2023)
TABLE 42 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2024-2030)
TABLE 43 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2017-2023)
TABLE 44 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2024-2030)
TABLE 45 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2017-2023)
TABLE 46 APAC BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2024-2030)
TABLE 47 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2017-2023)
TABLE 48 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2024-2030)
TABLE 49 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2017-2023)
TABLE 50 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2024-2030)
TABLE 51 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY COUNTRY (2017-2023)
TABLE 52 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUES (MILLION USD) BY COUNTRY (2024-2030)
TABLE 53 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2017-2023)
TABLE 54 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2024-2030)
TABLE 55 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2017-2023)
TABLE 56 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2024-2030)
TABLE 57 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2017-2023)
TABLE 58 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2024-2030)
TABLE 59 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2017-2023)
TABLE 60 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2024-2030)
TABLE 61 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2017-2023)
TABLE 62 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY COUNTRY (2024-2030)
TABLE 63 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MILLION USD) BY COUNTRY (2017-2023)
TABLE 64 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY COUNTRY (2024-2030)
TABLE 65 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2017-2023)
TABLE 66 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY TYPE (2024-2030)
TABLE 67 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2017-2023)
TABLE 68 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY TYPE (2024-2030)
TABLE 69 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2017-2023)
TABLE 70 MEA BCG TUBERCULOSIS VACCINE MARKET VOLUME (MN UNITS) BY APPLICATION (2024-2030)
TABLE 71 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2017-2023)
TABLE 72 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) BY APPLICATION (2024-2030)
TABLE 73 JAPAN BCG LABORATORY: COMPANY INFORMATION
TABLE 74 JAPAN BCG LABORATORY: PRODUCTS OFFERED
TABLE 75 JAPAN BCG LABORATORY: COMPANY FINANCIALS
TABLE 76 CHINA BIOTECHNOLOGY CO., LTD: COMPANY INFORMATION
TABLE 77 CHINA BIOTECHNOLOGY CO., LTD: PRODUCTS OFFERED
TABLE 78 CHINA BIOTECHNOLOGY CO., LTD: COMPANY FINANCIALS
TABLE 79 MERCK KGAA: COMPANY INFORMATION
TABLE 80 MERCK KGAA: PRODUCTS OFFERED
TABLE 81 MERCK KGAA: COMPANY FINANCIALS
TABLE 82 SERUM INSTITUTE OF INDIA PVT. LTD.: COMPANY INFORMATION
TABLE 83 SERUM INSTITUTE OF INDIA PVT. LTD.: PRODUCTS OFFERED
TABLE 84 SERUM INSTITUTE OF INDIA PVT. LTD.: PRODUCTS OFFERED.:
TABLE 85 GSBPL.: COMPANY INFORMATION
TABLE 86 GSBPL.: PRODUCTS OFFERED
TABLE 87 GSBPL.: COMPANY FINANCIALS
TABLE 88 AJ VACCINE: COMPANY INFORMATION
TABLE 89 AJ VACCINES.: PRODUCTS OFFERED
TABLE 90 AJ VACCINES.: COMPANY FINANCIALS
TABLE 91 STATENS SERUM INSTITUTE.: COMPANY INFORMATION
TABLE 92 STATENS SERUM INSTITUTE.: PRODUCTS OFFERED
TABLE 93 STATENS SERUM INSTITUTE.: COMPANY FINANCIALS
FIG. 1 RESEARCH PROCESES
FIG. 2 MARKET RESEARCH ESTIMATION METHODOLOGY
FIG. 3 FORECASTING MODEL
FIG. 4 MARKET SHARE ANALYSIS BY KEY PLAYERS, 2020
FIG. 5 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 6 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY REGION (2022)
FIG. 7 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 8 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 9 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 10 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 11 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 12 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY TYPE (2020)
FIG. 13 IMMUNE BCG: BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 14 THERAPY BCG: BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 15 GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY APPLICATIONS (2020)
FIG. 16 HOSPITALS: GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2018-2031)
FIG. 17 CLINICS: GLOBAL BCG TUBERCULOSIS VACCINE MARKET REVENUE (MILLION USD) (2017-2030)
FIG. 18 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY COUNTRY (2020)
FIG. 19 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY TYPE (2020)
FIG. 20 NORTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY APPLICATIONS (2020)
FIG. 21 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY COUNTRY (2020)
FIG. 22 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY TYPE (2020)
FIG. 23 EUROPE BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY APPLICATIONS (2020)
FIG. 24 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY COUNTRY (2020)
FIG. 25 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY TYPE (2020)
FIG. 26 APAC BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY APPLICATIONS (2020)
FIG. 27 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY COUNTRY (2020)
FIG. 28 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY TYPE (2020)
FIG. 29 SOUTH AMERICA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY APPLICATIONS (2020)
FIG. 30 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY COUNTRY (2020)
FIG. 31 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY TYPE (2020)
FIG. 32 MEA BCG TUBERCULOSIS VACCINE MARKET REVENUE MARKET SHARE (%) BY APPLICATIONS (2020)
Choose License Type
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
